Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2012
11/07/2012CN102764233A Liposome injection of 3-amino-6-aryl-thieno[2,3-b]pyridine-2-methanamide derivatives and preparation technology thereof
11/07/2012CN102764230A Nasal gel or ointment preparation for preventing and/or treating aspiration allergy
11/07/2012CN102764229A Compound haloperidol subcutaneously-implanted sustained-release agent and preparation and use methods thereof
11/07/2012CN102764198A Composition containing hydrogel particles
11/07/2012CN102362874B Leech colon targeted oral preparation and preparation method thereof
11/07/2012CN102327225B Tilmicosin liposome injection and preparation method thereof
11/07/2012CN102274203B Method for improving moisture resistance of L-carnitine tea polyphenol capsule inclusion
11/07/2012CN102258788B Targeted transmission assembly of adriamycin anticancer medicine and preparation method thereof
11/07/2012CN102228470B Preparation method and purpose of copper-loaded chitosan antiseptic
11/07/2012CN102225053B Vincristine nano targeting slow-release long-circulation liposome and preparation method thereof
11/07/2012CN102210746B Cream medicine composition for treating fungus infection of feet and preparation method thereof
11/07/2012CN102206306B Tumor-targeted carrier material as well as preparation method and application thereof
11/07/2012CN102188367B Insulin glargine injecta and preparation method thereof
11/07/2012CN102178814B Chinese medicinal composition for treating trichomonas vaginitis and preparation method thereof
11/07/2012CN102166293B Garlic oil navel paste and preparation method and application thereof
11/07/2012CN102133234B Medicines for treating gastric cancer prepared by toad peptide antibiotics
11/07/2012CN102114245B Special solvent for daidzein pre-emulsified injection and preparation method and purpose thereof
11/07/2012CN102106817B Pre-emulsified propylgallate concentrate and preparation thereof
11/07/2012CN102106812B Azithromycin ultrafine powder in-situ gel eye drops and preparation method thereof
11/07/2012CN102106809B Solid preparation of clopidogrel and preparation method thereof
11/07/2012CN102091052B Bicyclol double-layer osmotic pump control-released tablet and preparation method thereof
11/07/2012CN102085177B Reducible and degradable nano medicine-carrying micelle and preparation method thereof
11/07/2012CN102078595B Application of toad peptide antibiotic for preparing medicines for curing tinea manus and pedis
11/07/2012CN102078307B Medicine composition of dronedarone hydrochloride solid dispersion and preparation method thereof
11/07/2012CN102071461B Method for preparing titanium dioxide nanometer tubes and titanium dioxide nanometer tube preparation for loading enrofloxacin animal remedy
11/07/2012CN102068701B Application of cleavable polyethylene glycol (PEG) lipid derivative in preparation
11/07/2012CN102050953B Method for preparing reducible and degradable supermolecule hydrogel
11/07/2012CN102048699B Preparation method for sustained release microsphere of injection triptorelin acetate
11/07/2012CN102028954B Preparation of recombinant adenovirus
11/07/2012CN102020816B Polyvinyl formal sponge material with uniform abscesses and rapid imbibition and preparation method thereof
11/07/2012CN102010527B Chitosan nano particle and preparation method thereof
11/07/2012CN102008477B Method for preparing tablet drug composition containing Rosuvastatin calcium
11/07/2012CN101991633B Method for extracting tripterygium glycosides, and product and inclusion compound and medicinal composition thereof
11/07/2012CN101974138B Method for preparing amphiphilic gradient copolymer
11/07/2012CN101927005B Method for solubilizing carbon nano tube by using super-molecular complex and controlling solubility thereof by using light
11/07/2012CN101891814B Anti-osteopontin OPN monoclonal antibody and application thereof
11/07/2012CN101778870B Aqueous polymer dispersion based on n,n-diethylaminoethyl methacrylate, its preparation and use
11/07/2012CN101773465B Polymer micelle medicine carrying system using amino acid as stabilizing agent
11/07/2012CN101708173B Soft capsule and application thereof
11/07/2012CN101548960B High-dissolution oral bifendate capsule and preparation method thereof
11/07/2012CN101528266B Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1
11/07/2012CN101497878B Polypeptide of specific efficient affinity membrane type I substrate metal protease (MT1-MMP), protein and use
11/07/2012CN101461853B Chinese medicine granular formulation for relieving cough, dispelling phlegm and calming panting and preparation method thereof
11/07/2012CN101203245B Injection formula for RNA
11/07/2012CN101134110B Q type non-viral vector and pharmaceutical composition containing the same
11/07/2012CN101066260B Coenzyme Q10 emulsion and its freeze dried emulsion and their preparation process
11/07/2012CN101057834B Solid preparation comprising enteric solid dispersion
11/06/2012US8304511 Maleamic acid polymer derivatives and their bioconjugates
11/06/2012US8304497 Electrostatically bonded polymer vesicle
11/06/2012US8303991 Method of making particles for use in a pharmaceutical composition
11/06/2012US8303989 Compositions and methods for increasing the oral absorption of antimicrobials
11/06/2012US8303986 Hydrophilic/lipophilic polymeric matrix dosage formulation
11/06/2012US8303975 Implants for administering substances and methods of producing implants
11/06/2012US8303970 Polyamide-based powder and its use for obtaining an antibacterial coating
11/06/2012US8303966 Immunogenic substances comprising a polyinosinic acid—polycytidilic acid based adjuvant
11/06/2012US8303965 Polyinosinic acid-polycytidylic acid-based adjuvant
11/06/2012US8303933 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/06/2012US8303932 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/06/2012US8303643 Method and device for electrochemical formation of therapeutic species in vivo
11/06/2012CA2521909C Stabilising formulation for immunoglobulin g compositions in liquid form and in lyophilised form
11/06/2012CA2493083C Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
11/06/2012CA2412790C Liposomal antineoplastic drugs and uses thereof
11/06/2012CA2378751C Stable factor viii compositions
11/06/2012CA2365533C Diagnosis and treatment of neuroectodermal tumors
11/01/2012WO2012149454A2 Tolerogenic synthetic nanocarriers coupled to cd1d-restricted antigens and methods of use
11/01/2012WO2012149412A2 Anti-endoglin (cd105) antibodies, immunoconjugates, and uses thereof
11/01/2012WO2012149411A1 Controlled release of immunosuppressants from synthetic nanocarriers
11/01/2012WO2012149405A2 Tolerogenic synthetic nanocarriers for regulating innate immune responses
11/01/2012WO2012149393A2 Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cells
11/01/2012WO2012149376A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
11/01/2012WO2012149358A1 Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
11/01/2012WO2012149301A2 Tolerogenic synthetic nanocarriers for inducing regulatory b cells
11/01/2012WO2012149287A1 Solvent cast film sustained release latanoprost implant
11/01/2012WO2012149282A2 Tolerogenic synthetic nanocarriers for generating cd8+regulatory t cells
11/01/2012WO2012149278A1 Sustained release latanoprost implant
11/01/2012WO2012149265A2 Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses
11/01/2012WO2012149259A1 Tolerogenic synthetic nanocarriers to reduce antibody responses
11/01/2012WO2012149255A2 Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
11/01/2012WO2012149252A2 Tolerogenic synthetic nanocarriers
11/01/2012WO2012149247A2 Tolerogenic synthetic nanocarrier compositions with transplantable graft antigens and methods of use
11/01/2012WO2012149198A2 A method for manufacturing pegylated oligonucleotides
11/01/2012WO2012149160A2 Viruses modified with unnatural moieties and methods of use thereof
11/01/2012WO2012148799A1 Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
11/01/2012WO2012148538A2 Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglin
11/01/2012WO2012148181A2 Composition for the controlled-release of drugs
11/01/2012WO2012147986A1 Stable pharmaceutical composition
11/01/2012WO2012147873A1 Coating composition with superior oral disintegration characteristics
11/01/2012WO2012147842A1 Beautiful-skin-promoting agent and use thereof
11/01/2012WO2012147819A1 Biological function reviving agent
11/01/2012WO2012147805A1 Brain-targeting functional nucleic acid and use thereof
11/01/2012WO2012147714A1 NANOPARTICLES CONTAINING pH-RESPONSIVE PEPTIDE
11/01/2012WO2012147660A1 Rapidly dissolving oral tablet
11/01/2012WO2012147584A1 Suspended lotion containing imidazole-type anti-fungal agent
11/01/2012WO2012147171A1 Biological function reviving agent
11/01/2012WO2012146918A1 Biocidal coating composition
11/01/2012WO2012146917A1 Biocide-coated substrate
11/01/2012WO2012146901A1 Novel polypeptides and use thereof
11/01/2012WO2012146628A1 Novel immunoconjugates
11/01/2012WO2012146625A1 Lyophilized preparation of cytotoxic dipeptides
11/01/2012WO2012146218A1 Amphoteric materials based on crosslinked hyaluronic acid, method of preparation thereof, materials containing entrapped active agents, method of preparation thereof, and use of said materials
1 ... 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 ... 1712